O Micke

Summary

Country: Germany

Publications

  1. ncbi request reprint Selenium in the treatment of radiation-associated secondary lymphedema
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Int J Radiat Oncol Biol Phys 56:40-9. 2003
  2. ncbi request reprint Radiotherapy in painful heel spurs (plantar fasciitis)--results of a national patterns of care study
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Int J Radiat Oncol Biol Phys 58:828-43. 2004
  3. ncbi request reprint [Plantar fasciitis and radiotherapy. Clinical and radiobiological treatment results]
    O Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum, Munster
    Orthopade 34:579-91. 2005
  4. pmc Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study
    F J Prott
    Department of Radiotherapy, , Medical School, Germany
    Br J Cancer 75:597-601. 1997
  5. ncbi request reprint Alpha-fetoprotein-positive carcinoma of the pancreas: a case report
    S B Mueller
    Department of Radiotherapy, University Hospital Munster, Germany
    Anticancer Res 25:1671-4. 2005
  6. ncbi request reprint The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer
    O Micke
    Department of Radiotherapy and Radiation Oncology, University of Munster, Munster, Germany
    Anticancer Res 20:5113-5. 2000
  7. ncbi request reprint Fractionated perioperative high dose rate brachytherapy using a tissue equivalent bendy applicator
    S Könemann
    Department of Radiotherapy, University Hospital, Munster, Germany
    Br J Radiol 75:453-9. 2002
  8. ncbi request reprint Selenium in the treatment of head and neck lymphedema
    F Bruns
    Department of Radiotherapy, Medical School Hannover, Hannover, Germany
    Med Princ Pract 13:185-90. 2004
  9. ncbi request reprint Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Int J Radiat Oncol Biol Phys 57:90-7. 2003
  10. ncbi request reprint Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors
    Ulrich Schäfer
    Department of Radiotherapy, University Hospital Munster, Germany
    Strahlenther Onkol 179:527-34. 2003

Collaborators

Detail Information

Publications51

  1. ncbi request reprint Selenium in the treatment of radiation-associated secondary lymphedema
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Int J Radiat Oncol Biol Phys 56:40-9. 2003
    ..The aim of this explorative study was to evaluate the impact of selenium in the treatment of lymphedema after radiotherapy...
  2. ncbi request reprint Radiotherapy in painful heel spurs (plantar fasciitis)--results of a national patterns of care study
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Int J Radiat Oncol Biol Phys 58:828-43. 2004
    ..After a general patterns of care study, the German Cooperative Group on Radiotherapy for Benign Diseases conducted a multicenter cohort study to analyze radiotherapy (RT) in painful heel spur syndrome (HSS)...
  3. ncbi request reprint [Plantar fasciitis and radiotherapy. Clinical and radiobiological treatment results]
    O Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum, Munster
    Orthopade 34:579-91. 2005
    ..5 and 4.0 Gy. These results may provide a possible explanation for a local anti-inflammatory effect of low-dose RT. RT may be an excellent alternative for patients with contraindications to long-term treatment with steroids or NSAID...
  4. pmc Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study
    F J Prott
    Department of Radiotherapy, , Medical School, Germany
    Br J Cancer 75:597-601. 1997
    ..The therapy could be applied in a short period of time, approximately half the time used in conventional therapy schemes...
  5. ncbi request reprint Alpha-fetoprotein-positive carcinoma of the pancreas: a case report
    S B Mueller
    Department of Radiotherapy, University Hospital Munster, Germany
    Anticancer Res 25:1671-4. 2005
    ..Our patient is the youngest reported in the literature to date. When present, AFP expression is useful for diagnosis and as a marker for monitoring therapeutic response and recurrence of the disease...
  6. ncbi request reprint The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer
    O Micke
    Department of Radiotherapy and Radiation Oncology, University of Munster, Munster, Germany
    Anticancer Res 20:5113-5. 2000
    ..The leading time ranged between one and 16 months (median: 3.1 months). In conclusion, SCC is a useful tumor marker in the follow-up of patients with squamous cell carcinoma of the uterine cervix...
  7. ncbi request reprint Fractionated perioperative high dose rate brachytherapy using a tissue equivalent bendy applicator
    S Könemann
    Department of Radiotherapy, University Hospital, Munster, Germany
    Br J Radiol 75:453-9. 2002
    ....
  8. ncbi request reprint Selenium in the treatment of head and neck lymphedema
    F Bruns
    Department of Radiotherapy, Medical School Hannover, Hannover, Germany
    Med Princ Pract 13:185-90. 2004
    ..To investigate the impact of selenium in the treatment of lymphedema of the head and neck region after radiotherapy alone or in combination with surgery...
  9. ncbi request reprint Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Int J Radiat Oncol Biol Phys 57:90-7. 2003
    ..To determine the predictive value of carbohydrate antigen (CA) 19-9 in pancreatic cancer treated with radiochemotherapy...
  10. ncbi request reprint Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors
    Ulrich Schäfer
    Department of Radiotherapy, University Hospital Munster, Germany
    Strahlenther Onkol 179:527-34. 2003
    ..The purpose of this study was to analyze the prognostic value of baseline hemoglobin levels before radiotherapy in patients with head and neck tumors...
  11. ncbi request reprint [Long-term results of postoperative radiotherapy for stage I endometrial carcinoma]
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie Universitätsklinikum Münster, Munster
    Strahlenther Onkol 179:729-36. 2003
    ..The impact of an additional external beam irradiation of the pelvis considering different prognostic criteria is still unclear...
  12. ncbi request reprint Low-dose radiotherapy for painful heel spur. Retrospective study of 117 patients
    Ralph Mücke
    Department of Radiotherapy, Radiation Oncology and Nuclear Medicine, Weiden Hospital, Weiden, Germany
    Strahlenther Onkol 179:774-8. 2003
    ..Retrospective analysis of 117 patients treated between 1996 and 2000 with low-dose radiotherapy (RT) for painful heel spurs...
  13. ncbi request reprint Radiation therapy for nonmalignant diseases in Germany. Current concepts and future perspectives
    M Heinrich Seegenschmiedt
    Department of Radiation Oncology and Radiation Therapy, Alfried Krupp Hospital, Essen, Germany
    Strahlenther Onkol 180:718-30. 2004
    ..This development is reflected in a national patterns-of-care study (PCS) conducted during the years 2001-2002...
  14. ncbi request reprint [Legal questions in radio-oncology. Demands on patient information and documentation of the therapy with examples of current legal cases concerning specialization in radiotherapy/radio-oncology]
    Stefan Hesselmann
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, Munster, Germany
    Strahlenther Onkol 180:256-62. 2004
    ..As a rule-as a way out of difficulties-these claims for compensation are based on the accusation of mistaken or incomplete information, because if one cannot prove any wrong treatment, faulty information can (nearly) always be proven...
  15. ncbi request reprint Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national Patterns of Care Study
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Albert Schweitzer Strasse 33, 48129 Munster, Germany
    Int J Radiat Oncol Biol Phys 61:882-91. 2005
    ..After a general Patterns of Care Study (PCS) the German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) initiated a multicenter cohort study to analyze the radiation therapy practice for aggressive fibromatosis...
  16. ncbi request reprint Surgery and radiotherapy of one rare case with neoplasm derived from fibroblastic reticulum cells of a cervical lymph node
    Ralph Mücke
    Department of Radiotherapy, Klinikum Weiden, Germany
    Acta Oncol 43:766-8. 2004
  17. ncbi request reprint Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation
    Olaf Anselm Brinkmann
    Department of Urology, University Clinic of Muenster, Albert Schweitzer Strasse 33, 48149 Munster, Germany
    World J Urol 23:185-90. 2005
    ....
  18. pmc Randomized multicenter trial on the effect of radiotherapy for plantar Fasciitis (painful heel spur) using very low doses--a study protocol
    Marcus Niewald
    Department of Radiooncology, Saarland University Hospital, Homburg, Germany
    Radiat Oncol 3:27. 2008
    ..The trial is supported by a HOMFOR grant (Saarland University Research Grant). TRIAL REGISTRATION: Current controlled trials ISRCTN94220918...
  19. ncbi request reprint Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Westfalische Wilhelms Universitat, Munster, Germany
    Int J Radiat Oncol Biol Phys 52:496-513. 2002
    ....
  20. ncbi request reprint [Radiotherapy within the scope of allogeneic kidney transplantation: an indication for local irradiation?]
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster
    Strahlenther Onkol 178:280-5. 2002
    ..Despite major advantages in maintenance immunosuppression and management of acute allograft rejection a minority of patients remains with drug resistant transplant rejection. This subgroup of patients may benefit from LGI...
  21. ncbi request reprint Microscopic residual disease is a risk factor in the primary treatment of breast cancer
    Andreas Schuck
    Department of Radiotherapy of the University of Muenster, Germany
    Strahlenther Onkol 178:307-13. 2002
    ..In a retrospective analysis, our mono-institutional results of postoperative irradiation have been evaluated...
  22. ncbi request reprint Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapy
    Eckehard Horst
    Department of Radiation Oncology, University of Munster, Germany
    Front Radiat Ther Oncol 37:17-25. 2002
  23. ncbi request reprint Radiotherapy for Graves' orbitopathy: results of a national survey
    Reinhard Heyd
    Radiation Clinic, Offenbach Hospital, Offenbach, Germany
    Strahlenther Onkol 179:372-6. 2003
    ....
  24. ncbi request reprint Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network study
    Robert C Miller
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Radiother Oncol 80:323-6. 2006
    ..Patients received EBRT for bone pain, brain infiltration, or retro-orbital involvement. EBRT typically provided short-term palliation, with later recurrence of symptoms in most cases...
  25. ncbi request reprint Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Strahlenther Onkol 181:378-84. 2005
    ..To investigate the influence of radio- and chemotherapy, the treatment and course of the disease in children and adolescents with ENB were analyzed retrospectively...
  26. ncbi request reprint A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy
    Ulrich Schaefer
    Department of Radiotherapy and Radiooncology, University Hospital, Westfaelische Wilhelms University, Muenster, Germany
    Int J Radiat Oncol Biol Phys 52:192-7. 2002
    ....
  27. ncbi request reprint Radiotherapy in oncological emergencies--final results of a patterns of care study in Germany, Austria and Switzerland
    Elmar Christian
    Department of Internal Medicine, Paracelsus Hospital, Glückstadt, Germany
    Acta Oncol 47:81-9. 2008
    ..This study represents the largest database in literature on emergency RT. RT was shown to be fast, time sparing and a very effective treatment option for special oncological emergencies...
  28. ncbi request reprint No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy
    Frank Bruns
    Department of Radiotherapy, Hannover Medical School, Hannover, Germany
    Anticancer Res 25:1543-6. 2005
    ....
  29. ncbi request reprint PSA course after definitive high-dose radiotherapy of localized prostate cancer
    Patrick Schüller
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, Germany
    Anticancer Res 25:1555-7. 2005
    ..The aim of this analysis was to investigate whether PSA also declines to near zero values after combined tele-brachytherapy...
  30. ncbi request reprint The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Anticancer Res 25:1663-6. 2005
    ..In this retrospective analysis, the value of SCC correlated with prognosis in patients with carcinoma of the cervix treated with (chemo-)radiotherapy...
  31. ncbi request reprint Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up study
    Jens Büntzel
    Department of Otolaryngology, Head and Neck Surgery, Sudharzkrankenhaus Nordhausen, Nordhausen, Germany
    Anticancer Res 27:1953-6. 2007
    ..The late toxicities due to multimodal therapy of advanced head and neck cancers were analysed. The impact of cytoprotection with amifostine is the specific objective of this report...
  32. ncbi request reprint [Radiotherapy of Graves' ophthalmopathy--state of the art and review of the literature]
    Hans Theodor Eich
    Klinik und Poliklinik für Strahlentherapie, Klinikum der Universität zu Köln, Joseph Stelzmann Str 9, 50924 Köln, Germany
    Rontgenpraxis 56:137-44. 2007
    ..This article describes the sequences, dosages and fractionation schemes as well as the risks and side effects of the radiotherapy...
  33. ncbi request reprint 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas
    Patrick Schueller
    Department of Radiotherapy and Radiation Oncology, University Hospital, Muenster, Germany
    Strahlenther Onkol 181:500-6. 2005
    ..Even after surgery and radiotherapy, malignant gliomas still have a poor prognosis. The authors report on their experience with IORT in 71 patients...
  34. ncbi request reprint Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study
    Jens Buentzel
    Department of Otolaryngology, Head and Neck Surgery, Suedharzkrankenhaus Nodhausen, Nordhausen, Germany
    Int J Radiat Oncol Biol Phys 64:684-91. 2006
    ..This randomized, double-blinded, placebo-controlled, phase III study evaluated the efficacy and safety of i.v. amifostine during radiochemotherapy for head-and-neck cancer...
  35. ncbi request reprint 9 years tumor free survival after resection, intraoperative radiotherapy (IORT) and whole brain radiotherapy of a solitary brain metastasis of non-small cell lung cancer
    Patrick Schueller
    Acta Oncol 45:224-5. 2006
  36. ncbi request reprint Irradiation causes biphasic neutrophilic granulocyte phagocytic function
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Strahlenther Onkol 181:313-8; discussion 319. 2005
    ..The current study examines the influence of low radiation doses on neutrophilic granulocyte function, which could be helpful in finding the optimal dose for either stimulation or suppression of anti-inflammatory activity...
  37. ncbi request reprint Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early period
    Eckehard Horst
    Department of Radiation Oncology, University of Munster, Munster, Germany
    Int J Radiat Oncol Biol Phys 52:304-9. 2002
    ..To evaluate the functional effects of ionizing radiation in patients with unresectable pancreatic cancer in the early period after accelerated radiochemotherapy (ART)...
  38. ncbi request reprint Adjuvant radiotherapy in locally confined prostate cancer
    Ulrich Schäfer
    Department of Radiotherapy, University of Muenster, Albert Schweitzer Strasse 33, D 48129 Munster, Germany
    Anticancer Res 23:983-5. 2003
    ..The role of adjuvant radiotherapy (RT) following radical prostatectomy (RP) remains controversial. The aim of this study was to evaluate the benefit of adjuvant radiotherapy through PSA-level measurements...
  39. ncbi request reprint The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, Albert Schweitzer Str 33, 48129 Munster, Germany
    Anticancer Res 23:907-11. 2003
    ..This study examines the value of squamous cell cancer (SCC) antigen in patients irradiated for locally advanced cancer of the head and neck...
  40. ncbi request reprint CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy
    Oliver Micke
    Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, 48129 Munster, Germany
    Anticancer Res 23:835-40. 2003
    ..The aim of this study was to determine the value of CA 19-9 in therapy monitoring and follow-up of locally advanced pancreatic cancer treated by radiochemotherapy...
  41. ncbi request reprint Complementary and alternative medicine in radiotherapy patients--more harm than expected? In regard to D'Amico et al.: self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. IJRO
    Oliver Micke
    Int J Radiat Oncol Biol Phys 57:1197-8; author reply 1198. 2003
  42. ncbi request reprint Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma
    Hans Theodor Eich
    Department of Radiotherapy, University of Cologne, Germany
    Strahlenther Onkol 179:233-40. 2003
    ..To evaluate the efficacy of multimodality therapy in patients with esthesioneuroblastoma (ENB)...
  43. ncbi request reprint Influence of fractionated irradiation on neutrophilic granulocyte function
    Alfred Haidenberger
    Department of Radiotherapy, Leopold Franzens University Innsbruck, Austria
    Strahlenther Onkol 179:45-9. 2003
    ..In clinical practice, by contrast, fractionated irradiation is applied. Therefore, the aim of the current study was to verify the influence of fractionated radiation therapy on granulocyte function...
  44. ncbi request reprint The effect of sequential radiochemotherapy in preirradiated malignant gliomas in a phase II study
    Ulrich Schäfer
    Department of Radiotherapy, University of Muenster, Muenster, Germany
    J Neurooncol 67:233-9. 2004
    ..Palliative and survival benefits are modest. Evaluation of late toxicities needs further investigations...
  45. ncbi request reprint Long-term alterations of oral mucosa in radiotherapy patients
    Franz Josef Prott
    Department of Radiotherapy, University of Munster, Munster, Germany
    Int J Radiat Oncol Biol Phys 54:203-10. 2002
    ..The aim of this investigation was to describe the alterations in oral mucosa after radiotherapy...
  46. ncbi request reprint Current status of selenium and other treatments for secondary lymphedema
    Frank Bruns
    Department of Radiotherapy, Hannover Medical School, Hannover, Germany
    J Support Oncol 1:121-30. 2003
    ..The very low toxicity profile of selenium and its cost effectiveness are further arguments for its use in lymphedema treatment...
  47. ncbi request reprint Selenium influences the radiation sensitivity of C6 rat glioma cells
    Patrick Schueller
    Department of Radiotherapy and Radiation Oncology, University Hospital of Muenster, Germany
    Anticancer Res 24:2913-7. 2004
    ..A radioprotective effect of low selenium doses on normal tissue and a possible radiosensitization of tumor cells at higher concentrations have been previously suggested. However, systematic experimental and clinical data are scarce...
  48. ncbi request reprint Intraoperative radiation therapy (IORT) in primary locally advanced and recurrent carcinoma of the rectum at a "non-dedicated" facility
    Stefan Hesselmann
    Department of Radiotherapy and Radiooncology, University Hospital Muenster, D 48129 Muenster, Germany
    Anticancer Res 23:1875-81. 2003
    ..Our aim was to perform IORT at a "non-dedicated" facility to improve the local tumour control rate without increasing the complication rate...
  49. ncbi request reprint Systemic mast cell disease (SMCD) and bone pain. A case treated with radiotherapy
    Stefan Hesselmann
    Department of Radiotherapy and Radiooncology, University Hospital Muenster, Germany
    Strahlenther Onkol 178:275-9. 2002
    ..The cause of SMCD is unknown. Bony pain, caused by mast cell infiltration of the marrow cavity, is present in up to 28% of cases and is frequently chronic and difficult to palliate with medical therapy...
  50. ncbi request reprint Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients
    Frank Bruns
    Department of Radiation Oncology, University of Muenster, Albert Schweitzer Strasse 33, D 48129 Muenster, Germany
    Anticancer Res 23:1103-6. 2003
    ..During the follow-up of these patients after curative resection and radiotherapy the role of CEA for the detection of recurrent disease was determined retrospectively...
  51. ncbi request reprint Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy
    Oliver Micke
    Department of Radiotherapy, Munster University Hospital, Munster, Germany
    Anticancer Res 25:1523-30. 2005
    ..In locally advanced carcinoma of the exocrine pancreas combined radiochemotherapy has been established as a standard treatment...